Barnes, Alex
Mukherjee, Sutapa
Andrews, Jane M.
Spizzo, Paul
Mountifield, Réme
Funding for this research was provided by:
Ferring Pharmaceuticals
IBD-SA
Flinders University
Article History
Received: 19 February 2024
Accepted: 7 May 2024
First Online: 6 June 2024
Declarations
:
: Speakers fees, and Ad Boards from Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, BMS 2020, Celegene, Celltrion, Falk, Ferring, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Progenity, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020–2022, The Helmsley Trust 2020–2023.